Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study.
about
Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and FuturePrevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls.Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.Relative Risk of Acute Myocardial Infarction in People with Schizophrenia and Bipolar Disorder: A Population-Based Cohort Study.Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysisAn Untargeted Metabolomics Analysis of Antipsychotic Use in Bipolar DisorderLurasidone for the Treatment of Irritability Associated with Autistic DisorderDiabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis.The CHANGE trial: no superiority of lifestyle coaching plus care coordination plus treatment as usual compared to treatment as usual alone in reducing risk of cardiovascular disease in adults with schizophrenia spectrum disorders and abdominal obesiTransformation of excess mortality in people with schizophrenia and bipolar disorder in Taiwan.Simulated Effects of Policies to Reduce Diabetes Risk Among Adults With Schizophrenia Receiving Antipsychotics.Participants' Voices From Within a Healthy Lifestyle Group.Meta-analysis of population-based studies comparing risk of cerebrovascular accident associated with first- and second-generation antipsychotic prescribing in dementia.Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia.Use of antipsychotics and risk of myocardial infarction: a systematic review and meta-analysis.Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.Antipsychotic drug exposure and risk of myocardial infarction.Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies.The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions.Recovery from psychosis: physical health, antipsychotic medication and the daily dilemmas for mental health nurses.Cardiovascular Safety in Drug Development: A Role for Endothelial Function Tests.Risk of weight gain for specific antipsychotic drugs: a meta-analysis.Translational Significance of Selective Estrogen Receptor Modulators in Psychiatric Disorders
P2860
Q28394341-25281C43-04A5-4055-AA52-BA6B420715EDQ33670588-2D70A8F7-93A0-42F5-80BC-B81A2A7FE728Q33878816-3B3AF7C4-D8D2-4482-BAF5-844751E3ABADQ35744928-A42E8D61-6BBA-4C95-A703-79276CFE5CA8Q35754726-2B795BF6-2BC8-4647-BC67-05490B39C79CQ36118736-1C10BCB0-B3F4-4E60-810B-706E26D81CE7Q36225284-51DF9DCF-830A-42CA-896F-9506D0376B0BQ36674291-D4B0DD73-492F-4E4E-B3FF-72F3652E3406Q37015327-C5CDD615-B544-48EE-A27F-58F719D0AD57Q37015355-6FC2C704-82D6-4A2A-9603-9B835D79AC37Q38401379-E010520D-1044-463B-BAC5-887C2DC065C4Q38599502-FD6C1A12-5E3E-4D9C-829D-78A109A5BF7AQ38785766-5B5ACF65-F346-4D5A-8E64-E2C51F70DF38Q38819347-E7D3D0B7-C8C8-41EC-BB3C-F1588ECC3D90Q38837641-5EF22220-CB10-4A29-815A-DAC737EAC657Q38838870-EA94EB21-74C5-495C-A75D-2E7A88261733Q38842714-AF350577-4DE2-4891-8C70-85ECC17D4811Q39016420-FCA180D2-975E-4AB4-832F-199C26D45257Q39353717-BB62B037-1A48-410A-87B9-1719482E0021Q39417618-374463C3-646B-4F74-8EC0-D69691862CF9Q48151550-4384983A-8D87-4C88-A797-E61B2D48D0E9Q53139178-87F541B9-622E-4BCA-A9F6-76F3520CCF9AQ55513508-1F4B3F57-B5CC-44D3-A500-533049EA6019Q58580517-D0AF3B13-03E1-416F-A652-3AD538E8B4FB
P2860
Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cardiovascular and cerebrovasc ...... -based inception cohort study.
@ast
Cardiovascular and cerebrovasc ...... -based inception cohort study.
@en
type
label
Cardiovascular and cerebrovasc ...... -based inception cohort study.
@ast
Cardiovascular and cerebrovasc ...... -based inception cohort study.
@en
prefLabel
Cardiovascular and cerebrovasc ...... -based inception cohort study.
@ast
Cardiovascular and cerebrovasc ...... -based inception cohort study.
@en
P2093
P2860
P356
P1433
P1476
Cardiovascular and cerebrovasc ...... -based inception cohort study.
@en
P2093
Benjamin I Joffe
Christoph U Correll
Lisa M Rosen
Russell T Joffe
Timothy B Sullivan
P2860
P356
10.1002/WPS.20187
P407
P577
2015-02-01T00:00:00Z